Publications by authors named "Charles Fewlass"

Claim this Profile
S
Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial.
Manjusha J Gaglani, Pedro A Piedra, Mark Riggs, Gayla Herschler, Charles Fewlass

Pediatr Infect Dis J· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
Pedro A Piedra, Manjusha J Gaglani, Claudia A Kozinetz, Gayla B Herschler, Charles Fewlass

Pediatrics· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004.
M Elizabeth Halloran, Pedro A Piedra, Ira M Longini, Manjusha J Gaglani, Brian Schmotzer, Charles Fewlass

Vaccine· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.
Pedro A Piedra, Manjusha J Gaglani, Mark Riggs, Gayla Herschler, Charles Fewlass

Pediatrics· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children.
Pedro A Piedra, Manjusha J Gaglani, Claudia A Kozinetz, Gayla Herschler, Mark Riggs, Charles Fewlass

Vaccine· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children.
Manjusha J Gaglani, Pedro A Piedra, Gayla B Herschler, Melissa E Griffith, Claudia A Kozinetz, Charles Fewlass

Arch Pediatr Adolesc Med· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis